Jan Lindebjerg - Concepedia

Author

Jan Lindebjerg

Vejle Sygehus ORCID

Also Known As

J Lindebjerg, J. LINDEBJERG, J. Lindebjerg, J.A.N. Lindebjerg, JAN LINDEBJERG, Jan Lindebjerg, Lindebjerg, Jan

207

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Vejle Sygehus University of Southern Denmark Aarhus University Hospital Lillebaelt Hospital University of Copenhagen

About

Jan Lindebjerg is an author at Vejle Sygehus specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	34	2K
2	Health Sciences	7	7	918
3	Public Health	3	3	40
4	Natural Sciences	1	1	181
5	Allergy	1	1	65

Jan Lindebjerg

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study Ane Appelt, John Pløen, Henrik Harling, The Lancet Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineDistal Rectal Cancer	2015	539
A streamlined mass spectrometry–based proteomics workflow for large‐scale FFPE tissue analysis Fabian Coscia, Sophia Doll, Jacob Mathias Bech, The Journal of Pathology Biological Mass SpectrometryPathologyProteomic TechnologyClinical DiagnosisBiostatistics	2020	181
Neoadjuvant chemotherapy in locally advanced colon cancer.<b>A phase II trial</b> Anders Jakobsen, Fahimeh Andersen, Anders Fischer, Acta Oncologica	2015	110
Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer Lars Henrik Jensen, Jan Lindebjerg, Torben Frøstrup Hansen, Annals of Oncology Gastrointestinal OncologyMedicineBiliary CancerPathologyBiliary Disorder	2012	108
Dose-Effect Relationship in Chemoradiotherapy for Locally Advanced Rectal Cancer: A Randomized Trial Comparing Two Radiation Doses Anders Jakobsen, T. Vuong, Ane Appelt, International Journal of Radiation OncologyBiologyPhysics Dose-effect RelationshipRadiation TherapyRadiation DosesMedicineRadiation Dose	2012	104
The prognostic importance of miR-21 in stage II colon cancer: a population-based study Sanne Kjær‐Frifeldt, Torben Frøstrup Hansen, Boye Schnack Nielsen, British Journal of Cancer	2012	96
Virtual microscopy: an evaluation of its validity and diagnostic performance in routine histologic diagnosis of skin tumors Patricia Switten Nielsen, Jan Lindebjerg, Jan Rasmussen, Human Pathology Skin CancerMedical ImagingMicroscopyVirtual MicroscopyMicroscope Image Processing	2010	92
PET/CT and Histopathologic Response to Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer Charlotte Kristiansen, Annika Loft, Anne Kiil Berthelsen, Diseases of the Colon & Rectum	2007	87
High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer Mads H. Rasmussen, Niels F. Jensen, Line Schmidt Tarpgaard, Molecular Oncology	2013	86
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer K.-L.G. Spindler, Niels Pallisgaard, Audrey Rasmussen, Annals of Oncology Kras MutationsG PolymorphismGastrointestinal OncologyMedicinePathology	2009	75

Page 1